Physician Assistant · Auburn, MA
NPI
1881052462
Since 2016
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
207 Southbridge St
Auburn, MA, 01501
Phone (508) 832-7118
Groups this clinician bills Medicare through
Medicare paid, 2024
$127K
3,426 services
Medicare patients, 2024
1,104
Average age 73
Drug cost, 2024
$3.2M
2,605 prescriptions
Company payments, 2025
$3,242
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel Kwiecien was code 99213 (office e&m - established), 992 times for 800 patients. In total Daniel Kwiecien billed 3,426 services in 29 codes, and Medicare paid $127K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 992 | 800 | $49.33 | $49K |
| 17003 Destruction Skin Lesion | Office | 961 | 244 | $4.15 | $3,990 |
| 17000 Destruction Skin Lesion | Office | 436 | 358 | $38.25 | $17K |
| 17110 Destruction Skin Lesion | Office | 352 | 283 | $67.41 | $24K |
| 99203 Office E&M - New | Office | 161 | 161 | $53.71 | $8,648 |
| 11102 Skin Biopsy | Office | 152 | 145 | $57.49 | $8,738 |
| 99212 Office E&M - Established | Office | 148 | 134 | $31.84 | $4,713 |
| 99202 Office E&M - New | Office | 46 | 46 | $38.49 | $1,771 |
| 99214 Office E&M - Established | Office | 30 | 28 | $75.75 | $2,272 |
| 96372 Injection Administration | Office | 23 | 12 | $8.47 | $195 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 15 | 14 | $0.67 | $9.98 |
| 11900 Skin | Office | 15 | 14 | $30.51 | $458 |
| 11103 Skin Biopsy | Office | 14 | 12 | $32.40 | $454 |
| 10060 Skin | Office | 13 | 13 | $74.17 | $964 |
| 99204 Office E&M - New | Office | 12 | 12 | $78.45 | $941 |
By year: 2022 $126K for 3,444 services; 2023 $123K for 3,499 services; 2024 $127K for 3,426 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Kwiecien prescribed most often to Medicare patients was Triamcinolone Acetonide, with 352 prescriptions and refills. In total Daniel Kwiecien wrote 2,605 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 352 | 402 | 211 | $3,402 |
| Betamethasone Dipropionate Generic | 336 | 339 | 177 | $13K |
| Ketoconazole Generic | 184 | 186 | 69 | $3,175 |
| Fluocinonide Generic | 154 | 157 | 87 | $5,274 |
| Hydrocortisone Generic | 154 | 154 | 84 | $776 |
| Fluorouracil Generic | 131 | 131 | 108 | $8,011 |
| Dupixent Pen Dupilumab | 115 | 122 | 17 | $466K |
| Clobetasol Propionate Generic | 106 | 113 | 55 | $7,788 |
| Nystatin Generic | 93 | 93 | 52 | $1,177 |
| Metronidazole Generic | 89 | 99 | 45 | $5,774 |
| Doxycycline Hyclate Generic | 86 | 96 | 34 | $1,320 |
| Clindamycin Phosphate Generic | 80 | 81 | 46 | $2,828 |
| Humira(Cf) Pen Adalimumab | 52 | 52 | Under 11 | $362K |
| Prednisone Generic | 49 | 49 | 43 | $196 |
| Otezla Apremilast | 41 | 41 | Under 11 | $198K |
Brand drugs: 502 claims; generic drugs: 2,103 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel Kwiecien $3,242 ($3,242 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $645.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 25 | $645 |
| Genzyme Corporation SNY | 14 | $524 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $372 |
| Amgen Inc. AMGN | 10 | $316 |
| LEO Pharma Inc. | 10 | $292 |
| Janssen Biotech, Inc. JNJ | 12 | $287 |
| Galderma Laboratories, L.P. GALD.SW | 14 | $260 |
| Pfizer Inc. PFE | 9 | $203 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 6 | $114 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $79.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.